Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Keio University Research: Spotlight on the small intestine and human health


News provided by

Keio University

21 Jun, 2021, 04:04 GMT

Share this article

Share toX

Share this article

Share toX

TOKYO, June 21, 2021 /PRNewswire/ -- Researchers at Keio University, Japan, offer new insights into the adaptive immune system of the small intestine for new perspectives on host-microorganism symbiosis and organoid-based regeneration of the small intestine for treating short bowel syndrome. These findings were published in the journals Science Advances and Nature, respectively.  

The Keio Research Highlights website offers more details about this and other recent research being conducted by researchers at Keio University.

https://research-highlights.keio.ac.jp/

Mammalian systems have sophisticated mechanisms to control symbiosis with bacteria in the gut

Bacterial cells are enveloped by a protective coating made up of complex sugar molecules. Mammalian cells that are under bacterial attack have evolved over time to recognize these complex structures and trigger a combative response. In turn, bacteria have developed a clever mechanism to evade this response, where the sugars in their protective lining are linked closely to small molecules known as amino acids. Bacteria have learned to disguise these amino acids by changing their configuration slightly. Instead of using amino acids traditionally found in nature (L-amino acids), bacteria adopt mirror-image variants called D-amino acids (D-aa) into their envelopes. However, a team of molecular biologists led by Jumpei Sasabe at Keio University has recently shown that mammalian cells may also have a way to degrade D-aa in order to keep bacterial growth in check.

Mammalian systems are equipped with an enzyme called D-aa oxidase (DAO) that is responsible for detecting and degrading D-aa. To see how exactly DAO works, the team employed mice that had been genetically modified to disable DAO. Notably, these mice exhibited high levels of D-aa in their blood.

When the body detects bacteria, a defensive mechanism is initiated via several steps. White blood cells, named granulocytes and macrophages, take the bacteria into their cells (eat them, so to speak) and sterilize them. Since these innate immune systems work regardless of the type of bacteria, they are the frontline defence system. However, even this is not enough, the acquired immune system comes into play next. The main players are lymphocytes, a type of white blood cells that flow in the blood. B-lymphocytes produce antibodies (immunoglobulins) that fight bacteria and render them harmless. This is how we become "immunized" to germs. DAO regulates the latter process. The researchers used a series of experiments to investigate how the immune systems of mice with disabled DAO behaved when they detected D–aa released from bacteria in the gut. These mice showed exceedingly higher immunoglobulin A (IgA) levels compared to those with well–functioning DAO. They also had a greater number of transformative B-lymphocytes ready to produce IgA. Healthy DAO function was thus crucial in keeping D–aa–producing bacteria in check and controlling the subsequent immune response. Moreover, mice with impaired DAO function also showed signs of increased inflammation in the gut.

A certain number of bacteria reside permanently within the mammalian gut and aid with digestive function in exchange for a home. Maintaining this symbiotic relationship is important in preventing infections and keeping our gut health intact. This study shows that DAO is a key element in degrading D-aa thereby preventing excessive immune responses against symbiotic bacteria. "Our results reveal unexpected roles of D-aa catabolism by host DAO in the adaptive immune system of the small intestine and provide a new perspective on host-microbe symbiosis," conclude the researchers. A deeper understanding of this protective mechanism in mammalian species can also be useful in devising antibacterial strategies targeting D-aa.

Reference

Masataka Suzuki, Tomohisa Sujino, Sayako Chiba, Yoichi Harada, Motohito Goto, Riichi Takahashi, Masashi Mita, Kenji Hamase, Takanori Kanai, Mamoru Ito, Matthew Kaden Waldor, Masato Yasui, and Jumpei Sasabe. Host-microbe cross-talk governs amino acid chirality to regulate survival and differentiation of B cells. Science Advances, 2021, Vol. 7, no. 10, eabd6480

DOI: 10.1126/sciadv.abd6480

https://advances.sciencemag.org/content/7/10/eabd6480

Regenerating the small intestine

An organoid-based regenerative technique holds promise as a treatment for short bowel syndrome

In the human body, most of the digestion and absorption of food takes place in the small intestine (small bowel). In certain pathological situations, for example when the small intestine becomes blocked or infected or when tumors develop within the organ, it may need to be partly or completely surgically removed. This operation is called a small-intestine resection. An extensive resection can result in nutrients no longer being properly absorbed into the body, a condition that is known as short bowel syndrome (SBS). Symptoms of SBS include diarrhoea, dehydration, and weight loss, and in 50% of SBS cases, patients require the permanent intravenous administration of nutrition. Today, the only treatment for these patients is organ transplantation but the survival rate is low because of a high probability of the organ being rejected (as well as a shortage of donors). Alternative treatment options are much needed.

One such alternative approach currently being explored is based on advances in regenerative medicine—the term refers to the development of methods for regrowing tissue with specific functions or even organs. A breakthrough in this line of research with implications for SBS has now been reported by Shinya Sugimoto from Keio University and his colleagues, who have succeeded in generating a small-intestine-like organ that mimics the food-absorbing capabilities of the small intestine.

The scientists first created organoids from the tissue of the small intestine—the organoids are essentially cultured clusters of small-intestine stem cells. They speculated that when transplanting organoids to the large intestine (also known as the colon, which is located after the small intestine), a 'small intestinalized colon (SIC)' might form that is able to perform (some of) the functions of the small intestine. Experiments on mice showed that indeed, transplanted organoids can reconstitute small-intestine tissue and absorption capabilities. Importantly, the researchers confirmed the formation of villi—small, finger-like protrusions occurring everywhere in the small intestine and playing a key role in the nutrient absorption process.

To test the therapeutic potential of a SIC, the researchers performed experiments on rats. Parts of the rats' small intestines were removed, leading to SBS, after which SICs were created using the rats' large intestines. The scientists observed that intestinal failure in the SBS rats was reduced significantly. The results suggest that the SIC can perform the function of the small intestine and, importantly, that it can remodel its so-called lymphovascular structure. The latter refers to the highly complex structure of vessels carrying blood and other liquids around within the small intestine.

The findings of Sugimoto and his colleagues hold promise for treating SBS, as even a short residual small intestine (as the result of a resection operation) is still a rich enough source for creating organoids and therefore a SIC. In the words of the researchers, "These data provide a proof of principle for the use of intestinal organoids for regenerative purposes, and offer a feasible strategy for SBS treatment."

Reference

Shinya Sugimoto, Eiji Kobayashi, Masayuki Fujii, Yuki Ohta, Kazuya Arai, Mami Matano, Keiko Ishikawa, Kentaro Miyamoto, Kohta Toshimitsu, Sirirat Takahashi, Kosaku Nanki, Yoji Hakamata, Takanori Kanai, Toshiro Sato, An organoid-based organ-repurposing approach to treat short bowel syndrome, Nature 592, 99–104 (2021).

https://doi.org/10.1038/s41586-021-03247-2

Websites

Keio University
https://www.keio.ac.jp/en/

Keio Research Highlights
https://research-highlights.keio.ac.jp/

About Keio University

Keio University is a private, comprehensive university with six major campuses in the Greater Tokyo area along with a number of affiliated academic institutions. Keio prides itself on educational and research excellence in a wide range of fields and its state-of-the-art university hospital.

Keio was founded in 1858, and it is Japan's first modern institution of higher learning. Over the last century and a half, it has evolved into and continues to maintain its status as a leading university in Japan through its ongoing commitment to producing leaders of the future. Founder Yukichi Fukuzawa, a highly respected educator and one of the most important intellectuals of modern Japan, aspired for Keio to be a pioneer of new discoveries and contribute to society through.

Further information

Keio University
Office of Research Development and Sponsored Projects
2-15-45 Mita, Minato-ku, Tokyo 108-8345 Japan
E-mail: keio-rpr@adst.keio.ac.jp

Modal title

Also from this source

Keio University Research: Genomic Insights for Personalized Cancer Treatment

In a recent paper published in Cancer Discovery, Keio University's Sara Horie and her colleagues conducted an in-depth analysis of cancer driver...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Biotechnology

Biotechnology

STEM (Science, Tech, Engineering, Math)

STEM (Science, Tech, Engineering, Math)

Computer & Electronics

Computer & Electronics

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.